NewslettersImmune Regulation News Antibody-Mediated Blockade of the IL23 Receptor Destabilizes Intratumoral Regulatory T Cells and Enhances Immunotherapy By Danielle Corrigan - May 3, 2022 0 Researchers provided evidence that the interleukin 23 (IL23) receptor expressed by tumor-infiltrating regulatory T cells promoted suppressive activity. [Proceedings of the National Academy of Sciences of the United States of America] Abstract